Oculogyric crisis induced by high-dose apomorphine in a patient with advanced Parkinson's disease [0.03%]
高剂量化脓菌素诱发的帕金森病患者的眼肌痉挛发作
Negin Eissazade,Elizabeth Slow,Anthony E Lang et al.
Negin Eissazade et al.
Verbal fluency in Parkinson's disease with mild cognitive impairment: quantitative, qualitative, and semantic network analyses [0.03%]
帕金森病轻度认知障碍患者的语言流畅性：定量、定性和语义网络分析
Alfonso Delgado-Álvarez,Lucía Fernández-Romero,María Valles-Salgado et al.
Alfonso Delgado-Álvarez et al.
Background: Verbal fluency (VF) tasks are widely used in the cognitive assessment of Parkinson's disease (PD). However, the total number of correct responses does not capture all aspects of performance, and the underlying...
Automated assessment of susceptibility map-weighted imaging in patients with clinically uncertain parkinsonism [0.03%]
帕金森病临床诊断自动评估中的易感性地图加权成像分析
Elon D Wallert,Elsmarieke van de Giessen,Martijn Beudel et al.
Elon D Wallert et al.
Background and objectives: In patients with a clinically uncertain parkinsonian syndrome (CUPS), the novel MRI sequence susceptibility map-weighted imaging (SMWI) may be a diagnostic alternative to dopamine transporter (D...
Temporal trends and risk factors of hospital readmission following deep brain stimulation for Parkinson disease [0.03%]
帕金森病脑深部刺激术后再入院的危险因素及时间趋势研究
Daniel G Di Luca,Adam de Havenon,Anagha Prabhune et al.
Daniel G Di Luca et al.
Background: Risk factors and long-term data on readmissions following deep brain stimulation (DBS) for Parkinson Disease (PD) remain unclear. Objective: ...
Introducing a workflow algorithm for adaptive DBS programming in Parkinson's disease [0.03%]
一种针对帕金森病自适应深部脑刺激编程的工作流算法的介绍
Saar Anis,Patricia A Clark,Shannon Shaffer et al.
Saar Anis et al.
Background: Adaptive deep brain stimulation (aDBS) utilizing BrainSense™ technology by Medtronic Percept™ stimulator, is a recent advancement that dynamically adjusts stimulation in real-time based on the power of frequ...
Comparative pharmacokinetics of levodopa-carbidopa intestinal gel infusion and foslevodopa-foscarbidopa continuous subcutaneous infusion therapies in advanced Parkinson's disease [0.03%]
左旋多巴-卡比多巴肠凝胶输注与富马酸左旋多巴-富马酸卡比多巴皮下输注治疗晚期帕金森病的药代动力学比较研究
Yohei Mukai,Junko Takei,Juri Nomoto et al.
Yohei Mukai et al.
Introduction: Levodopa-carbidopa intestinal gel therapy (LCIG) and foslevodopa-foscarbidopa continuous subcutaneous infusion therapy (FOCS) are device-aided therapies for advanced Parkinson's disease. Comparative real-wor...
Motor-planning cerebello-cerebral network alterations in PRRT2-related paroxysmal kinesigenic dyskinesia [0.03%]
与PRLT2基因相关的节律性运动障碍患者的脑-小脑网络异常
Weihao Liao,Yingying Zhang,Jiechuan Ren et al.
Weihao Liao et al.
Background and objectives: Emerging preclinical evidence suggests that the cerebellum plays a critical role in paroxysmal kinesigenic dyskinesia (PKD) associated with proline-rich transmembrane protein 2 (PRRT2) mutations...
Influence of hypokinetic dysarthria severity level on the long-term outcome of repetitive transcranial magnetic stimulation therapy [0.03%]
轻度与中重度制动性构音障碍患者经颅磁刺激治疗的远期疗效差异研究
Krystof Novotny,Lubos Brabenec,Jiri Mekyska et al.
Krystof Novotny et al.
Introduction: Hypokinetic dysarthria (HD) is a common and disabling symptom of Parkinson's disease (PD) for which established pharmacological and surgical treatments bring only limited, often short-term improvement in spe...
Recruitment strategies for the racial disparities in Parkinson's disease study: Partnering with patients from the Black community [0.03%]
帕金森病种族差异研究的招聘策略：与黑人社区患者合作
Jacqueline Vanegas,Rebecca Weimer,Nathan Krinickas et al.
Jacqueline Vanegas et al.
Introduction: Most Parkinson's Disease (PD) studies fail to recruit diverse racial and ethnic groups in their study sample. PD research mainly contains data from White PD patients and fails to reflect the experiences of B...